Lead sponsor
Bigespas LTD
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
1
Ongoing
583
Total enrollment
15
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Phase 3
1
Trials by status
Recruiting
1
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementiamild-to-moderate ADPh 3Recruiting450